Provided by Tiger Trade Technology Pte. Ltd.

Verastem

7.55
+0.23003.14%
Post-market: 7.45-0.1000-1.32%19:30 EDT
Volume:1.73M
Turnover:13.30M
Market Cap:683.75M
PE:-3.13
High:7.91
Open:7.58
Low:7.54
Close:7.32
52wk High:10.82
52wk Low:3.43
Shares:90.56M
Float Shares:70.57M
Volume Ratio:0.83
T/O Rate:2.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4143
EPS(LYR):-3.0223
ROE:-471.16%
ROA:-49.59%
PB:13.68
PE(LYR):-2.50

Loading ...

Buy Rating on Verastem: Favorable Risk‑Reward for VS‑7375 Driven by Superior Early Efficacy vs. Zoldonrasib and Improving Safety Outlook

TIPRANKS
·
Apr 21

Verastem Price Target Maintained With a $19.00/Share by BTIG

Dow Jones
·
Apr 21

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sundrug Co (OtherSDGCF) and Verastem (VSTM)

TIPRANKS
·
Apr 13

Verastem Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 11

Verastem Says Avmapki, Fakzynja Combination Sustains Benefits for 2 Years in Ovarian Cancer

MT Newswires Live
·
Apr 10

BRIEF-Verastem Oncology Announces Two-Year Median Follow-Up Data On Avmapki® Fakzynja® Combination Therapy

Reuters
·
Apr 10

Verastem says RAMP 201 shows durable benefit for AVMAPKI-FAKZYNJA in recurrent ovarian cancer

Reuters
·
Apr 10

Verastem Oncology Announces Two-Year Median Follow-up Data on Avmapki® Fakzynja® Combination Therapy (Avutometinib Capsules; Defactinib Tablets) in Recurrent Low-Grade Serous Ovarian Cancer at the Sgo 2026 Annual Meeting on Women’s Cancers

THOMSON REUTERS
·
Apr 10

RBC Capital Sticks to Their Buy Rating for Verastem (VSTM)

TIPRANKS
·
Apr 09

GenFleet says China grants breakthrough designation for GFH375 in metastatic pancreatic cancer

Reuters
·
Apr 09

BRIEF-Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 03

Verastem Oncology grants 141,000 restricted stock units to 11 new employees

Reuters
·
Apr 03

Verastem Coverage Assumed by Jefferies at Buy

Dow Jones
·
Mar 31

Verastem assumed with a Buy at Jefferies

TIPRANKS
·
Mar 30

Verastem management to meet with Cantor

TIPRANKS
·
Mar 27

GenFleet FY2025 net loss widens to RMB 1.79 billion as revenue rises 24.41% to RMB 130 million

Reuters
·
Mar 25